RT Journal Article
SR Electronic
T1 Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e000775
DO 10.1136/jitc-2020-000775
VO 8
IS 1
A1 Rischin, Danny
A1 Migden, Michael R
A1 Lim, Annette M
A1 Schmults, Chrysalyne D
A1 Khushalani, Nikhil I
A1 Hughes, Brett G M
A1 Schadendorf, Dirk
A1 Dunn, Lara A
A1 Hernandez-Aya, Leonel
A1 Chang, Anne Lynn S
A1 Modi, Badri
A1 Hauschild, Axel
A1 Ulrich, Claas
A1 Eigentler, Thomas
A1 Stein, Brian
A1 Pavlick, Anna C
A1 Geiger, Jessica L
A1 Gutzmer, Ralf
A1 Alam, Murad
A1 Okoye, Emmanuel
A1 Mathias, Melissa
A1 Jankovic, Vladimir
A1 Stankevich, Elizabeth
A1 Booth, Jocelyn
A1 Li, Siyu
A1 Lowy, Israel
A1 Fury, Matthew G
A1 Guminski, Alexander
YR 2020
UL http://jitc.bmj.com/content/8/1/e000775.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.